Secretome Therapeutics Announces $30 Million Series A Financing
From RA Capital Management to Advance STM-01 for Duchenne-Associated Cardiomyopathy
May 27, 2026
Ready to Advertise?
Learn More
Let’s work together.
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
From RA Capital Management to Advance STM-01 for Duchenne-Associated Cardiomyopathy
Let’s work together.